The HOPE Study: Characterizing Patients With Hepatitis B and C
An Omnibus Protocol to Characterize Patients With Hepatitis B and C (the HOPE Study) With Hepatitis B Treatment Sub-study
Sponsor: University of Maryland, Baltimore
A observational or N/A phase clinical study on Hepatitis B， Chronic and Hepatitis C, this trial is actively recruiting participants. The trial is conducted by University of Maryland, Baltimore and has accumulated 14 data snapshots since 2014. Infectious disease trials contribute critical data for public health response and treatment development.
Status Flow
Change History
14 versions recorded-
Jun 2025 — Present [monthly]
Recruiting
-
Sep 2024 — Jun 2025 [monthly]
Recruiting
-
Jul 2024 — Sep 2024 [monthly]
Recruiting
-
May 2024 — Jul 2024 [monthly]
Recruiting
-
Apr 2023 — May 2024 [monthly]
Recruiting
▶ Show 9 earlier versions
-
Feb 2022 — Apr 2023 [monthly]
Recruiting
-
Jan 2021 — Feb 2022 [monthly]
Recruiting
-
Sep 2019 — Jan 2021 [monthly]
Recruiting
-
Jul 2019 — Sep 2019 [monthly]
Recruiting
-
Jun 2018 — Jul 2019 [monthly]
Recruiting
-
Apr 2018 — Jun 2018 [monthly]
Recruiting
Phase: NA → None
-
Jun 2017 — Apr 2018 [monthly]
Recruiting NA
-
Feb 2017 — Jun 2017 [monthly]
Recruiting NA
Status: Active Not Recruiting → Recruiting
-
Jan 2017 — Feb 2017 [monthly]
Active Not Recruiting NA
First recorded
Dec 2014
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- University of Maryland, Baltimore
For direct contact, visit the study record on ClinicalTrials.gov .